{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:50:33Z","timestamp":1779911433072,"version":"3.53.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1989]]},"DOI":"10.1007\/bf00442564","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T23:46:26Z","timestamp":1100216786000},"page":"S73-S76","source":"Crossref","is-referenced-by-count":84,"title":["Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia ? a retrospective study of 387 patients"],"prefix":"10.1007","volume":"99","author":[{"given":"D.","family":"Naber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leppig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hippius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","series-title":"Psychopharmacology Series","first-page":"923","volume-title":"Psychotherapeutic drugs, Part I+II","author":"M Ackenheil","year":"1977","unstructured":"Ackenheil M, Hippius H (1977) Clozapine. In: Usdin E, Forrest JS (eds) Psychotherapeutic drugs, Part I+II, Psychopharmacology Series, vol II. Dekker, New York, pp 923?956"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0447.1977.tb00224.x","volume":"56","author":"HA Amsler","year":"1977","unstructured":"Amsler HA, Leerenhovi L, Barth E, Harjula K, Vuopio P (1977) Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic. Acta Psychiatr Scand 56:241?248","journal-title":"Acta Psychiatr Scand"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0028-1094313","volume":"13","author":"J Angst","year":"1971","unstructured":"Angst J, Bente D, Berner P, Heiman H, Helmchen H, Hippius H (1971a) Das klinische Wirkungsbild, von Clozapin Untersuchung mit dem AMP-System). Pharmakopsychiatrie 13:201?211","journal-title":"Pharmakopsychiatrie"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-0028-1094312","volume":"13","author":"J Angst","year":"1971","unstructured":"Angst J, Jaenicke U, Padrutt A, Scharfetter C (1971b) Ergebnisse eines Doppelblindversuchs von Clozapin (8-Chlor-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4) diazepin) im Vergleich zu Levomepromazin, Pharmakopsychiatrie 13:192?200","journal-title":"Pharmakopsychiatrie"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-1017443","volume":"16","author":"D Bauer","year":"1983","unstructured":"Bauer D, Gartner HJ (1983) Wirkungen der Neuroleptika auf die Leberfunktion, das blutbildende System, den Blutdruck und die Temperaturregulation. Pharmakopsychiatrie 16:23?29","journal-title":"Pharmakopsychiatrie"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0028-1094343","volume":"5","author":"A Blum","year":"1972","unstructured":"Blum A, Mauruschat W (1972) Temperaturanstiege und Bluteiwei\u00dfver\u00e4nderungen unter der Therapie mit Neuroleptika unter besonderer Ber\u00fccksichtigung des neuartigen Dibenzodiazepin-Derivates Clozapin. Pharmakopsychiatrie 5:155?169","journal-title":"Pharmakopsychiatrie"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/ajp.136.3.317","volume":"136","author":"ED Caine","year":"1979","unstructured":"Caine ED, Polinsky RJ, Kartzinel R, Ebert MH (1979) The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 136:317?320","journal-title":"Am J Psychiatry"},{"key":"CR8","first-page":"785","volume":"137","author":"G Carroll","year":"1977","unstructured":"Carroll G, Curtis J, Kokmen E (1977) Paradoxical response to dopamine agonists in tardive dyskinesia. Am J Psychiatry 137:785?789","journal-title":"Am J Psychiatry"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/BF00442559","volume":"99","author":"DE Casey","year":"1989","unstructured":"Casey DE (1989) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology [Suppl] 99:S47-S53","journal-title":"Psychopharmacology [Suppl]"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-198712000-00002","volume":"7","author":"J Claghorn","year":"1987","unstructured":"Claghorn J, Honigfeld G, Abuzzahab FS, Wang R, Steinbock R, Tuason V, Klerman G (1987) The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7:377?384","journal-title":"J Clin Psychopharmacol"},{"key":"CR11","first-page":"945","volume":"16","author":"B Ekblom","year":"1974","unstructured":"Ekblom B, H\u00e4ggstr\u00f6m JE (1974) Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Curr Ther Res 16:945?957","journal-title":"Curr Ther Res"},{"key":"CR12","first-page":"1706","volume":"24","author":"K Fischer-Cornelssen","year":"1974","unstructured":"Fischer-Cornelssen K, Ferner U, Steiner H (1974) Multifokale Psychopharmakapr\u00fcfung (?Multihospital Trial?). Arzneimittelforschung\/Drug Res 24:1706?1724","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0028-1094609","volume":"12","author":"M Fink","year":"1979","unstructured":"Fink M, Irwin P, Weinhold P (1979) EEG profile studies of clozapine in volunteers and psychiatric patients. Pharmakopsychiatrie 12:184?190","journal-title":"Pharmakopsychiatrie"},{"key":"CR14","first-page":"238","volume":"40","author":"AJ Gelenberg","year":"1979","unstructured":"Gelenberg AJ, Doller JC (1979) Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. J Clin Psychiatry 40:238?240","journal-title":"J Clin Psychiatry"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00427742","volume":"59","author":"J Gerlach","year":"1978","unstructured":"Gerlach J, Simmelsgaard H (1978) Tardive dyskinesia during and following treatment with haloperidol+biperiden, thioridazine, and clozapine. Psychopharmacology 59:105?112","journal-title":"Psychopharmacology"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0447.1974.tb09706.x","volume":"50","author":"J Gerlach","year":"1974","unstructured":"Gerlach J, Koppelhus E, Helweg E, Monrad A (1974) Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50:410?424","journal-title":"Acta Psychiatr Scand"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00421473","volume":"40","author":"J Gerlach","year":"1975","unstructured":"Gerlach J, Thorsen K, Fog R (1975) Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacologia 40:341?350","journal-title":"Psychopharmacologia"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1007\/BF00442573","volume":"99","author":"R Grohmann","year":"1989","unstructured":"Grohmann R, Schmidt LG, Spie\u00df-Kiefer C, Ruether R (1989) Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AM\u00dcP program. Psychopharmacology [Suppl] 99:S109-S112","journal-title":"Psychopharmacology [Suppl]"},{"key":"CR19","first-page":"987","volume":"24","author":"H Gross","year":"1974","unstructured":"Gross H, Langner E, Pfolz H (1974) Clozapin in der Langzeittherapie der chronischen Schizophrenie. Arzneimittelforschung\/Drug Res 24:987?989","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"CR20","first-page":"707","volume":"21","author":"E Guirguis","year":"1977","unstructured":"Guirguis E, Voineskos G, Gray J, Schlieman E (1977) Clozapine (Leponex) versus chlorpromazin (Largactil) in acute schizophrenia (a double-blind controlled study). Curr Ther Res 21:707?719","journal-title":"Curr Ther Res"},{"key":"CR21","doi-asserted-by":"crossref","unstructured":"Hippius H (1989) History of clozapine. Psychopharmacology (in press)","DOI":"10.1007\/BF00442551"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00606409","volume":"11","author":"J Id\u00e4\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1977","unstructured":"Id\u00e4\u00e4np\u00e4\u00e4n-Heikkil\u00e4 J, Alhava E, Olkinvora M, Palva I (1977) Agranulocytosis during treatment with clozapine. Eur J Clin Pharmacol 11:193?198","journal-title":"Eur J Clin Pharmacol"},{"key":"CR23","first-page":"268","volume":"47","author":"H Iseman","year":"1976","unstructured":"Iseman H, Haupt R (1976) Auff\u00e4llige EEG-Ver\u00e4nderungen unter Clozapin-Behandlung bei paranoid-hallozinatorischen Psychosen. Nervenarzt 47:268","journal-title":"Nervenarzt"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clzapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789?796","journal-title":"Arch Gen Psychiatry"},{"key":"CR25","first-page":"465","volume":"32","author":"A Kirkegaard","year":"1982","unstructured":"Kirkegaard A, Hammershoj E, Ostergard P (1982) Evaluation of side effects due to clozapine in long-term tratment of psychosis. Arzneimittelforschung\/Drug Res 32:465?468","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0028-1094608","volume":"12","author":"M Koukkou","year":"1979","unstructured":"Koukkou M, Angst J, Zimmer D (1979) Paroxysmal EEG activity and psychopathology during the treatment with clozapine. Pharmakopsychiatrie 12:173?183","journal-title":"Pharmakopsychiatrie"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/08039488609096470","volume":"40","author":"S Kuha","year":"1986","unstructured":"Kuha S, Miettinen E (1986) Long-term effect of clozapine in schizophrenia. A retrospective study of 108 chronic schizophrenics treated with clozapine for up to 7 years. Nord Psykiatr Tidsskr 40:225?230","journal-title":"Nord Psykiatr Tidsskr"},{"key":"CR28","first-page":"391","volume":"27","author":"YD Lapierre","year":"1980","unstructured":"Lapierre YD, Ghadirian A, St-Laurent J, Chaudhry RP (1980) Clozapine in acute schizophrenia-efficacy and toxicity. Curr Ther Res 27:391?400","journal-title":"Curr Ther Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/BF00442565","volume":"99","author":"M Leppig","year":"1989","unstructured":"Leppig M, Bosch B, Naber D, Hippius H (1989) Clozapine in the treatment of 121 out-patients. Psychopharmacology [Suppl] 99:S77-S79","journal-title":"Psychopharmacology [Suppl]"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1600-0447.1988.tb05164.x","volume":"77","author":"LH Lindstr\u00f6m","year":"1988","unstructured":"Lindstr\u00f6m LH (1988) The effect of long-therm treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 77:524?529","journal-title":"Acta Psychiatr Scand"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00004714-198410000-00010","volume":"4","author":"HY Meltzer","year":"1984","unstructured":"Meltzer HY, Luchins DJ (1984) Effect of clozapine in severe tardive dyskinesia: a case report. J Clin Psychopharmacol 4:286?287","journal-title":"J Clin Psychopharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0447.1985.tb01268.x","volume":"71","author":"UJ Povisen","year":"1985","unstructured":"Povisen UJ, Noring U, Fog R, Gerlach J (1985) Tolerability and therapeutic effect of clozapine for up to 12 years. Acta Psychiatr Scand 71:176?185","journal-title":"Acta Psychiatr Scand"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1979.01780060047005","volume":"36","author":"B Shopsin","year":"1979","unstructured":"Shopsin B, Klein H, Aaronsom M, Collora M (1979) Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients. Arch Gen Psychiatry 36:657?664","journal-title":"Arch Gen Psychiatry"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00571412","volume":"56","author":"GM Simpson","year":"1978","unstructured":"Simpson GM, Varga E (1978) Clozapine in tardive dyskinesia. Psychopharmacology 56:75?80","journal-title":"Psychopharmacology"},{"key":"CR35","first-page":"263","volume":"48","author":"JG Small","year":"1987","unstructured":"Small JG, Milstein V, Marhenke JD, Hall DD, Kellams JJ (1987) Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. J Clin Psychiatry 48:263?267","journal-title":"J Clin Psychiatry"},{"key":"CR36","first-page":"1499","volume":"28","author":"R Spatz","year":"1978","unstructured":"Spatz R, Lorenzi E, Kugler J, R\u00fcther E (1978) H\u00e4ufigkeit und Form von EEG-Anomalien bei Clozapintherapie. Arzneimittelforschung 28:1499?1500","journal-title":"Arzneimittelforschung"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0028-1094311","volume":"4","author":"G Stille","year":"1971","unstructured":"Stille G, Hippius H (1971) Kritische Stellungnahme zum Begriff der Neuroleptika. Pharmacopsychiatry 4:182?191","journal-title":"Pharmacopsychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00442564.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00442564\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00442564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T20:38:34Z","timestamp":1554323914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00442564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989]]},"references-count":37,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1989]]}},"alternative-id":["BF00442564"],"URL":"https:\/\/doi.org\/10.1007\/bf00442564","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989]]}}}